Provitro AG

Your expert in target validation

Provitro has more than ten years of experience in commercialization of cell culture technologies and tissue microarrays backed up by scientific knowledge and resources of immunohistochemical analyses at the Pathological Institute of Charité Universitätsmedizin Berlin.

They have added medical research to their own expertise in biotechnology to create solutions to common problems in life sciences. Provitro’s team has raised its sights to the interface between research and development to establish new solutions to benefit future research projects. Their hallmarks are competence, vision and sustainability.

Based on a quality management system certified according to ISO 9001 and ISO 13485, they provide customers with high-quality products.